These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19246445)

  • 21. Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report.
    Sofuoglu M; Herman AI; Li Y; Waters AJ
    Psychopharmacology (Berl); 2012 Dec; 224(3):413-20. PubMed ID: 22700039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.
    Rose JE; Behm FM; Westman EC; Levin ED; Stein RM; Ripka GV
    Clin Pharmacol Ther; 1994 Jul; 56(1):86-99. PubMed ID: 8033499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intolerance for smoking abstinence among nicotine-deprived, treatment-seeking smokers.
    Germeroth LJ; Baker NL; Saladin ME
    Addict Behav; 2018 Sep; 84():13-19. PubMed ID: 29597136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.
    Jones JD; Babalonis S; Marcus R; Vince B; Kelsh D; Lofwall MR; Fraser H; Paterson B; Martinez S; Martinez DM; Nunes EV; Walsh SL; Comer SD
    Addict Biol; 2020 Jul; 25(4):e12799. PubMed ID: 31240842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why two smoking cessation agents work better than one: role of craving suppression.
    Bolt DM; Piper ME; Theobald WE; Baker TB
    J Consult Clin Psychol; 2012 Feb; 80(1):54-65. PubMed ID: 22103958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tobacco withdrawal components and their relations with cessation success.
    Piper ME; Schlam TR; Cook JW; Sheffer MA; Smith SS; Loh WY; Bolt DM; Kim SY; Kaye JT; Hefner KR; Baker TB
    Psychopharmacology (Berl); 2011 Aug; 216(4):569-78. PubMed ID: 21416234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence.
    Leischow SJ; Valente SN; Hill AL; Otte PS; Aickin M; Holden T; Kligman E; Cook G
    Exp Clin Psychopharmacol; 1997 Feb; 5(1):54-64. PubMed ID: 9234040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Withdrawal Symptoms From E-Cigarette Abstinence Among Former Smokers: A Pre-Post Clinical Trial.
    Hughes JR; Peters EN; Callas PW; Peasley-Miklus C; Oga E; Etter JF; Morley N
    Nicotine Tob Res; 2020 Apr; 22(5):734-739. PubMed ID: 31352486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?
    Rezaishiraz H; Hyland A; Mahoney MC; O'Connor RJ; Cummings KM
    Nicotine Tob Res; 2007 Nov; 9(11):1139-46. PubMed ID: 17978987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.
    Aubin HJ; Bobak A; Britton JR; Oncken C; Billing CB; Gong J; Williams KE; Reeves KR
    Thorax; 2008 Aug; 63(8):717-24. PubMed ID: 18263663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy.
    Shiffman S; Ferguson SG; Gwaltney CJ; Balabanis MH; Shadel WG
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):637-44. PubMed ID: 16261317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
    Selby P; Andriash K; Zawertailo L; Persad D; Zack M; Busto UE
    J Clin Psychopharmacol; 2013 Oct; 33(5):667-74. PubMed ID: 23963055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal changes in smoking abstinence symptoms and alternative reinforcers predict long-term smoking cessation outcomes.
    Schnoll RA; Hitsman B; Blazekovic S; Veluz-Wilkins A; Wileyto EP; Leone FT; Audrain-McGovern JE
    Drug Alcohol Depend; 2016 Aug; 165():245-52. PubMed ID: 27372219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The transdermal nicotine patch: results of a randomised placebo-controlled trial.
    Richmond RL; Harris K; de Almeida Neto A
    Med J Aust; 1994 Jul; 161(2):130-5. PubMed ID: 8028537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varying nicotine patch dose and type of smoking cessation counseling.
    Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
    JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
    Evins AE; Culhane MA; Alpert JE; Pava J; Liese BS; Farabaugh A; Fava M
    J Clin Psychopharmacol; 2008 Dec; 28(6):660-6. PubMed ID: 19011435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.
    Daughton DM; Fortmann SP; Glover ED; Hatsukami DK; Heatley SA; Lichtenstein E; Repsher L; Millatmal T; Killen JD; Nowak RT; Ullrich F; Patil KD; Rennard SI
    Prev Med; 1999 Feb; 28(2):113-8. PubMed ID: 10048102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A contingent payment model of smoking cessation: effects on abstinence and withdrawal.
    Heil SH; Tidey JW; Holmes HW; Badger GJ; Higgins ST
    Nicotine Tob Res; 2003 Apr; 5(2):205-13. PubMed ID: 12745493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of oral transmucosal nicotine lozenge for suppression of withdrawal symptoms in smoking abstinence.
    Muramoto ML; Ranger-Moore J; Leischow SJ
    Nicotine Tob Res; 2003 Apr; 5(2):223-30. PubMed ID: 12745495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Airway sensory replacement combined with nicotine replacement for smoking cessation. A randomized, placebo-controlled trial using a citric acid inhaler.
    Westman EC; Behm FM; Rose JE
    Chest; 1995 May; 107(5):1358-64. PubMed ID: 7750331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.